Head

Stanislav Spanik

Studied at the Medical Faculty Charles University Prague and Medical Faculty Commenius University Bratislava. He became board-certified in Internal Medicine, Haematology and Blood Transfusion, and Clinical Oncology. The title PhD in Internal Medicine he received at the School of Medicine Commenius University. He became Professor in Public Health at the School of Nursing and Public Health University of Trnava.

He attended postgraduate education and training at the Department of Medicine, Memorial Sloan-Kettering Cancer Centre in New York and Mayo Clinic in Rochester in United States.

He is a member of Slovak Medical Association, Slovak Society of Clinical Oncology, Slovak Society of Haematology and Transfusiology, European Society for Medical Oncology, American Society of Clinical Oncology.

He participated in many international clinical trials, gave  few invited lectures at many prestigious oncology conferences and is the author of many articles, books and book chapters in the field of oncology.

Currently he is a head of Department of Medicine and Medical Oncology St. Elizabeth Cancer Institute in Bratislava and State Secretary of Ministry of Health of Slovak Republic.

Peter Berzinec

is a medical oncologist, Head of the Department of Oncology, and Associated Professor at the Hospital of St Zoerardus Zobor, Nitra, Teaching Base of the Slovak Medical University Bratislava, Slovakia. He did his postgraduate training in internal medicine, pulmonology, and oncology in Slovakia, with short visits to Hospital of TB and Respiratory Diseases, Coswig, Dresden, Uster Hospital, Zurich, University of Colorado Cancer Center, Denver, The Meyerstein Institute of Oncology, London and The Christie Hospital, Manchester. He is a Committee member of the Slovak Oncology Society, a Committee member of the Slovak Chemotherapeutic Society, and a member of the Slovak Pneumological Society. He is a Fellow of the American College of Chest Physicians (ACCP), member of the International Association for the Study of Lung Cancer (IASLC), European Society for Medical Oncology (ESMO), and American Society of Clinical Oncology (ASCO). He is also a Member of the Scientific Board of the Slovak League against Cancer.